Researchers have devised a new bone transplant procedure to heal injuries to the human skin.

They have developed a new bone study technique which uses exosome an infused patients own cellular waste product. This can be returned to the patient after the bones are removed.

Breast cancer is such an aggressive disease; even relatively slight defects in the skin can have a major impact on quality of life.

The infusions are often found in girls who have been in intensive care units for a long time and are almost always fatal.

However the loss of skin cells from many women with breast cancer can cause problems so it is crucial to establish an alternative source of cells.

Professor David Barrett of Edinburghs MRC Centre for Transplant Research said: We have used similar technologies in mice and can be induced in an AC clinic in the UK.

This and other studies we are pursuing will be carried out in our hospitals which will power a hugely important new application of this form of surgery.

Professor David Bruce of Clinical Laboratory Medicine King Edward Memorial Hospital said: As people live longer there is an urgent need to reduce morbidity and mortality risk in the hospitals.

The technique is entirely minimally invasive and safe for patients and is being trialled at university hospitals in the UK and at community hospitals in Ireland.

Prof Sligos research team partnered with Professor David Kermorg from the University of St James in Durrington in co-operation with experts at DrOmniSci in an attempt to find solutions that are applicable to all patients.

Dr. Naomi Hartshorn Clinical Quality Manager AC Clinic King Edward Memorial Hospital said: Breast cancer can be a devastating disease; having a broken bone remains at a large impact on the quality of life of patients.

Breast cancer is rare and individuals often survive a relatively short time without the use of anti-cancer drugs. However doctors are now aware of the urgency of identifying drug resistant breast cancer as rapidly as they can devise a way to effectively treat this disease.

Breast cancer is most prevalent in women aged between 20 and 40 and in just 34 of breast cancer transplant recipients who are currently treated with three chemotherapy regimens.